A DAP12-mediated pathway regulates expression of CC chemokine receptor 7 and maturation of human dendritic cells
Open accessAbstract
Gene targeting of the adaptor molecule DAP12 in mice caused abnormal distribution and impaired antigen presentation capacity of dendritic cells (DCs). However, the DAP12-associated receptors expressed on DCs and their functions have not been identified yet. Here we show that the triggering receptor expressed on myeloid cells-2 (TREM-2) is a cell surface receptor on human monocyte-derived DCs, which is associated with DAP12. TREM-2/DAP12 promotes upregulation of CC chemokine receptor 7, partial DC maturation, and DC survival through activation of protein tyrosine kinases and extracellular signal-regulated kinase. In contrast to Toll-like receptor-mediated signaling, TREM2/DAP12 stimulation is independent of nuclear factor-kappaB and p38 stress-activated protein kinase. This novel DC activation pathway may regulate DC homeostasis and amplify DC responses to pathogens, explaining the phenotype observed in DAP12-deficient mice.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
TREM2 associates with DAP12 to induce signal transduction, including recruitment and activation of SYK and calcium flux.
“TREM2 associates with the immunoreceptor tyrosine-based activation motif (ITAM)–containing adaptor protein DAP12 to induce signal transduction, including recruitment and activation of spleen tyrosine kinase (SYK) and calcium flux24,25.”
From PLCγ2 regulates TREM2 signalling and integrin-mediated adhesion and migration of human iPSC-derived macrophages (2021) · cites this paper as [25]
The Results (page not specified) show that TREM-2 associates with DAP12 and that TREM-2 ligation causes calcium flux in human monocyte-derived dendritic cells. The Discussion identifies DAP12 as an ITAM-containing adaptor and reports PTK and ERK signaling, but our copy does not show recruitment or activation of SYK by TREM-2. (LLM, conf=0.88)
Experimental — accuracy not yet measuredTREM2 is induced in human monocytes and mouse bone marrow cells upon exposure to GM-CSF and CSF-1.
“We have previously shown that TREM2 is induced in human monocytes and mouse bone marrow cells upon exposure to GM-CSF and CSF-1 (Bouchon et al., 2001; Turnbull et al., 2006).”
From TREM2 Modulation Remodels the Tumor Myeloid Landscape Enhancing Anti-PD-1 Immunotherapy (2020) · cites this paper as Bouchon et al., 2001
The Results section on immature monocyte-derived dendritic cells reports high TREM-2 expression after human monocytes were cultured with GM-CSF and IL-4. It does not report induction in mouse bone marrow cells or by CSF-1; in fact, TREM-2 was undetectable in human monocyte-derived macrophages cultured with M-CSF. No page number is available in our copy. (LLM, conf=0.88)
Experimental — accuracy not yet measuredTREM2 expression was first observed in macrophages and dendritic cells, but not granulocytes or monocytes.
“TREM2 expression was first observed in macrophages and dendritic cells, but not granulocytes or monocytes (9–11).”
From <i>Trem2</i> promotes anti-inflammatory responses in microglia and is suppressed under pro-inflammatory conditions (2020) · cites this paper as [10]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Dendritic cells and the control of immunity
Banchereau, J., & Steinman, R. M. (1998) · Nature · doi:10.1038/32588 · Cited by 14,244 · see citing works
The Bcl-2 Protein Family: Arbiters of Cell Survival
Adams, J. M., & Cory, S. (1998) · Science · doi:10.1126/science.281.5381.1322 · Cited by 5,303 · see citing works
NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune Responses
Ghosh, S., May, M. J., & Kopp, E. B. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.225 · Cited by 5,182 · see citing works
Sallusto, F., & Lanzavecchia, A. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.179.4.1109 · Cited by 5,129 · see citing works
Phosphorylation meets ubiquitination: the control of NF-κB activity
Karin, M., & Ben-Neriah, Y. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.621 · Cited by 4,766 · see citing works
Nicoletti, I., Migliorati, G., Pagliacci, M. C., Grignani, F., & Riccardi, C. (1991) · Journal of Immunological Methods · doi:10.1016/0022-1759(91)90198-o · Cited by 4,580 · see citing works
Schreiber, E. H., Matthias, P., Müller, M. M., & Schaffner, W. (1989) · Nucleic Acids Research · doi:10.1093/nar/17.15.6419 · Cited by 4,179 · see citing works
Zlotnik, A., & Yoshie, O. (2000) · Immunity · doi:10.1016/s1074-7613(00)80165-x · Cited by 3,859 · see citing works
BCL-2 family members and the mitochondria in apoptosisPreprint
Gross, A., McDonnell, J. M., & Korsmeyer, S. J. (1999) · Genes & Development · doi:10.1101/gad.13.15.1899 · Cited by 3,623 · see citing works
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph node organogenesis.
Kong, Y.-Y., Yoshida, H., Sarosi, I., Tan, H.-L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A. J., Van, G., Itie, A., et al. (1999) · Nature · doi:10.1038/16852 · Cited by 3,351 · see citing works
Toll-like receptors in the induction of the innate immune response
Aderem, A. A., & Ulevitch, R. J. (2000) · Nature · doi:10.1038/35021228 · Cited by 3,047 · see citing works
Förster, R., Schubel, A., Breitfeld, D., Kremmer, E., Renner‐Müller, I., Wolf, E., & Lipp, M. (1999) · Cell · doi:10.1016/s0092-8674(00)80059-8 · Cited by 2,348 · see citing works
A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function.
Anderson, D. M., Maraskovsky, E., Billingsley, W. L., Dougall, W. C., Tometsko, M. E., Roux, E. R., Teepe, M. C., DuBose, R. F., Cosman, D., & Galibert, L. (1997) · Nature · doi:10.1038/36593 · Cited by 2,290 · see citing works
Cella, M., Scheidegger, D., Palmer-Lehmann, K., Lane, P. J. L., Lanzavecchia, A., & Alber, G. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.2.747 · Cited by 1,982 · see citing works
Self-citationMedzhitov, R. M., & Janeway, C. A. (2000) · New England Journal of Medicine · doi:10.1056/nejm200008033430506 · Cited by 1,827 · see citing works
Ravetch, J. V., & Bolland, S. M. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.275 · Cited by 1,653 · see citing works
Natural adjuvants: Endogenous activators of dendritic cells
Gallucci, S., Lolkema, M. P., & Matzinger, P. (1999) · Nature Medicine · doi:10.1038/15200 · Cited by 1,601 · see citing works
Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells.
Macatonia, S. E., Hosken, N. A., Litton, M. J., Vieira, P., Hsieh, C., Culpepper, J., Wysocka, M., Trinchieri, G., MURPHY, K. M. M., & O’Garra, A. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.10.5071 · Cited by 1,524 · see citing works
Dieu‐Nosjean, M., Vanbervliet, B., Vicari, A. P., Bridon, J., Oldham, E., Aït‐Yahia, S., Brière, F., Zlotnik, A., Lebecque, S., & Caux, C. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.2.373 · Cited by 1,424 · see citing works
Sauter, B., Albert, M. L., Francisco, L. M., Larsson, M., Somersan, S., & Bhardwaj, N. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.3.423 · Cited by 1,357 · see citing works
Bouchon, A., Dietrich, J., & Colonna, M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.10.4991 · Cited by 1,284 · cited 8× · see citing works
“TREM-1 is preferentially expressed on neutrophils and a subset of blood monocytes (53).”
BackgroundResultInfluentialTargeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses
Sha, W. C., Liou, H.-C., TUOMANEN, E. I., & Baltimore, D. (1995) · Cell · doi:10.1016/0092-8674(95)90415-8 · Cited by 1,158 · see citing works
Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells
Cella, M., Engering, A. J., Pinet, V., Pieters, J., & Lanzavecchia, A. (1997) · Nature · doi:10.1038/42030 · Cited by 1,123 · see citing works
Self-citationTREM-1 amplifies inflammation and is a crucial mediator of septic shock
Bouchon, A., Facchetti, F., Weigand, M. A., & Colonna, M. (2001) · Nature · doi:10.1038/35074114 · Cited by 1,092 · see citing works
Self-citationBH3-Only Proteins—Essential Initiators of Apoptotic Cell Death
Huang, D. C. S., & Strasser, A. (2000) · Cell · doi:10.1016/s0092-8674(00)00187-2 · Cited by 1,044 · see citing works
An Activating Immunoreceptor Complex Formed by NKG2D and DAP10
Wu, J., Song, Y., Bakker, A. B. H., Bauer, S., Spies, T. A., Lanier, L. L., & Phillips, J. H. (1999) · Science · doi:10.1126/science.285.5428.730 · Cited by 1,037 · see citing works
Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells
Lanier, L., Corliss, B., Wu, J., Leong, C., & Phillips, J. (1998) · Nature · doi:10.1038/35642 · Cited by 1,025 · see citing works
Gunn, M. D., Kyuwa, S., Tam‐Amersdorfer, C., Kakiuchi, T., Matsuzawa, A., Williams, L. T., & Nakano, H. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.3.451 · Cited by 1,019 · see citing works
Green, D. R. (2000) · Cell · doi:10.1016/s0092-8674(00)00003-9 · Cited by 1,011 · see citing works
Series Introduction: The transcription factor NF-κB and human disease
Baldwin, A. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11891 · Cited by 990 · see citing works
Koch, F., Stanzl, U., Jennewein, P., Janke, K., Heufler, C., Kämpgen, E., Romani, N., & Schuler, G. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.2.741 · Cited by 928 · see citing works
Régnault, A., Lankar, D., Lacabanne, V., Rodrı́guez, A., Théry, C., Rescigno, M., Saito, T., Verbeek, S. J., Bonnerot, C., Ricciardi‐Castagnoli, P., et al. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.2.371 · Cited by 897 · see citing works
Differential Requirements for Survival and Proliferation of CD8 Naïve or Memory T Cells
Tanchot, C., Lemonnier, F. A., Pérarnau, B., Freitas, A. A., & Rocha, B. (1997) · Science · doi:10.1126/science.276.5321.2057 · Cited by 856 · see citing works
Köntgen, F., Grumont, R. J., Strasser, A., Metcalf, D., Li, R., Tarlinton, D. M., & Gerondakis, S. (1995) · Genes & Development · doi:10.1101/gad.9.16.1965 · Cited by 727 · see citing works
Heufler, C., Koch, F., Stanzl, U., Topar, G., Wysocka, M., Trinchieri, G., Enk, A., Steinman, R. M., Romani, N., & Schuler, G. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260323 · Cited by 700 · see citing works
Bender, A., Sapp, M., Schuler, G., et al. (1996) · Journal of Immunological Methods · doi:10.1016/0022-1759(96)00079-8 · Cited by 675 · see citing works
Dendritic Cell Survival and Maturation Are Regulated by Different Signaling Pathways
Rescigno, M., Martino, M., Sutherland, C. L., Gold, M. R., & Ricciardi‐Castagnoli, P. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.11.2175 · Cited by 675 · see citing works
A family of proteins that inhibit signalling through tyrosine kinase receptors
Kharitonenkov, A., Chen, Z., Sures, I., Wang, H., Schilling, J., & Ullrich, A. (1997) · Nature · doi:10.1038/386181a0 · Cited by 662 · see citing works
Saeki, H., Moore, A. M., Brown, M. J., & Hwang, S. T. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.5.2472 · Cited by 623 · see citing works
Sozzani, S., Allavena, P., D’Amico, G., Luini, W., Bianchi, G., Kataura, M., Imai, T., Yoshie, O., Bonecchi, R., & Mantovani, A. (1998) · PubMed · Cited by 605 · see citing works
Association of DAP12 with Activating CD94/NKG2C NK Cell Receptors
Lanier, L. L., Corliss, B. C., Wu, J., & Phillips, J. H. (1998) · Immunity · doi:10.1016/s1074-7613(00)80574-9 · Cited by 560 · see citing works
Ngo, V. N., Körner, H., Gunn, M. D., Schmidt, K. N., Riminton, S., Cooper, M. D., Browning, J. L., Sedgwick, J. D., & Cyster, J. G. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.2.403 · Cited by 552 · see citing works
Sozzani, S., Allavena, P., D’Amico, G., Luini, W., Bianchi, G., Kataura, M., Imai, T., Yoshie, O., Bonecchi, R., & Mantovani, A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.3.1083 · Cited by 507 · see citing works
Robbiani, D. F., Finch, R. A., Jäger, D., Müller, W. A., Sartorelli, A. C., & Randolph, G. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00179-3 · Cited by 455 · see citing works
Cantoni, C., Bottino, C., Vitale, M., Pessino, A. M., Augugliaro, R., Malaspina, A., Parolini, S., Moretta, L., Moretta, A., & Biassoni, R. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.5.787 · Cited by 450 · see citing works
Baeuerle, P. A. (1998) · Cell · doi:10.1016/s0092-8674(00)81694-3 · Cited by 443 · see citing works
Ardeshna, K. M., Pizzey, A. R., Devereux, S., & Khwaja, A. (2000) · Blood · doi:10.1182/blood.v96.3.1039 · Cited by 430 · see citing works
Expression and function of OX40 ligand on human dendritic cells
Ohshima, Y., Tanaka, Y., Tozawa, H., Takahashi, Y., Maliszewski, C. R., & Delespesse, G. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.8.3838 · Cited by 420 · see citing works
Arrighi, J.-F., Rebsamen, M. C., Rousset, F., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.6.3837 · Cited by 403 · see citing works
Regulation of Bad Phosphorylation and Association with Bcl-xL by the MAPK/Erk Kinase
Scheid, M. P., Schubert, K. M., & Duronio, V. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.43.31108 · Cited by 389 · see citing works
EBI1/CCR7 Is a New Member of Dendritic Cell Chemokine Receptor That Is Up-Regulated upon Maturation
Yanagihara, S., Komura, E., Nagafune, J., Watarai, H., & Yamaguchi, Y. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.6.3096 · Cited by 370 · see citing works
Lanzavecchia, A. (1998) · Nature · doi:10.1038/30845 · Cited by 364 · see citing works
Arch, R. H., & Thompson, C. B. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.1.558 · Cited by 356 · see citing works
Josien, R., Li, H.-L., Ingulli, E., Sarma, S., R.Wong, B., Vologodskaia, M., Steinman, R. M., & Choi, Y. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.3.495 · Cited by 334 · see citing works
Ox40-Ligand Has a Critical Costimulatory Role in Dendritic Cell:T Cell Interactions
Chen, A. I., McAdam, A. J., Buhlmann, J. E., Scott, S., Lupher, M., Greenfield, E. A., Baum, P. R., Fanslow, W. C., Calderhead, D. M., Freeman, G. J., et al. (1999) · Immunity · doi:10.1016/s1074-7613(00)80143-0 · Cited by 321 · see citing works
Scheid, M. P., & Duronio, V. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7439 · Cited by 305 · see citing works
Doi, T. S., Takahashi, T., Taguchi, O., Azuma, T., & Obata, Y. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.5.953 · Cited by 292 · see citing works
Impairment of Antigen-Presenting Cell Function in Mice Lacking Expression of Ox40 Ligand
Murata, K., Ishii, N., Takano, H., Miura, S., Ndhlovu, L. C., Nose, M., Noda, T., & Sugamura, K. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.2.365 · Cited by 281 · see citing works
Ly-49D and Ly-49H associate with mouse DAP12 and form activating receptors.
Smith, K. M., Wu, J., Bakker, A. B. H., Phillips, J. H., & Lanier, L. L. (1998) · PubMed · Cited by 277 · see citing works
Klein, J. B., Rane, M. J., Scherzer, J. A., Coxon, P. Y., Kettritz, R., Mathiesen, J. M., Buridi, A., & McLeish, K. R. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.8.4286 · Cited by 269 · see citing works
DAP12-deficient mice fail to develop autoimmunity due to impaired antigen priming.
Bakker, A. B., Hoek, R., Cerwenka, A., Blom, B., Lucian, L., McNeil, T., Murray, R., Phillips, L., Sedgwick, J., & Lanier, L. (2000) · Immunity · doi:10.1016/s1074-7613(00)00034-0 · Cited by 269 · see citing works
Olcese, L., Cambiaggi, A., Semenzato, G., Bottino, C., Moretta, A., & Vivier, É. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.11.5083 · Cited by 262 · see citing works
Bachmann, M. F., Wong, B. R., Josien, R., Steinman, R. M., Oxenius, A., & Choi, Y. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.7.1025 · Cited by 260 · see citing works
Cutting Edge: Ly-49D and Ly-49H Associate with Mouse DAP12 and Form Activating Receptors
Smith, K. M., Wu, J., Bakker, A. B. H., Phillips, J. H., & Lanier, L. L. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.1.7 · Cited by 249 · see citing works
Lin, Y. C., Brown, K., & Siebenlist, U. K. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.2.552 · Cited by 246 · see citing works
Bakker, A. B. H., Baker, E. G., Sutherland, G. R., Phillips, J. H., & Lanier, L. L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.17.9792 · Cited by 210 · see citing works
DAP12-mediated Signal Transduction in Natural Killer Cells
McVicar, D. W., Taylor, L. S., Gosselin, P., Willette‐Brown, J., Mikhael, A., Geahlen, R. L., Nakamura, M. C., Linnemeyer, P. A., Seaman, W. E., Anderson, S. K., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.49.32934 · Cited by 210 · see citing works
Kawamata, S., Hori, T., Imura, A., Takaori‐Kondo, A., & Uchiyama, T. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.10.5808 · Cited by 200 · see citing works
Interleukin-18 Activates NF-κB in Murine T Helper Type 1 Cells
Matsumoto, S., Tsuji‐Takayama, K., Aizawa, Y., Koide, K., Takeuchi, M., Ohta, T., & Kurimoto, M. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6665 · Cited by 198 · see citing works
Tomasello, E., Olcese, L., Vely, F., Geourgeon, C., Bléry, M., Moqrich, A., Gautheret, D., Djabali, M., Mattéi, M., & Vivier, É. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.51.34115 · Cited by 186 · see citing works
Nakano, H., Mori, S., Yonekawa, H., Nariuchi, H., Matsuzawa, A., & Kakiuchi, T. (1998) · Blood · doi:10.1182/blood.v91.8.2886.2886_2886_2895 · Cited by 184 · see citing works
Seiffert, M., Brossart, P., Cant, C., Cella, M., Colonna, M., Brugger, W., Kanz, L., Ullrich, A., & Bühring, H. (2001) · Blood · doi:10.1182/blood.v97.9.2741 · Cited by 183 · see citing works
Self-citationMartínez‐Lorenzo, M. J., Álava, M. A., Gamen, S., Kim, K. J., Chuntharapai, A., Piñeiro, A., Naval, J., & Anel, A. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199809)28:09 · Cited by 182 · see citing works
Nakajima, H., Samaridis, J., Ångman, L., & Colonna, M. (1999) · PubMed · Cited by 173 · see citing works
Self-citationDietrich, J., Cella, M., Seiffert, M., Bühring, H., & Colonna, M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.1.9 · Cited by 172 · see citing works
Self-citationTomasello, E., Desmoulins, P.-O., Chemin, K., Guia, S., Cremer, H., Ortaldo, J. R., Love, P. E., Kaiserlian, D., & Vivier, É. (2000) · Immunity · doi:10.1016/s1074-7613(00)00035-2 · Cited by 159 · see citing works
Hernández-Munaín, C., & Krangel, M. S. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.1.473 · Cited by 153 · see citing works
Nakajima, H., Samaridis, J., Ångman, L., & Colonna, M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.1.5 · Cited by 152 · see citing works
Self-citationRichards, D. F., Fernandez, M., Caulfield, J., & Hawrylowicz, C. M. (2000) · European Journal of Immunology · doi:10.1002/1521-4141(2000)30:8 · Cited by 133 · see citing works
Fc receptor signaling and trafficking: a connection for antigen processing
Amigorena, S., & Bonnerot, C. (1999) · Immunological Reviews · doi:10.1111/j.1600-065x.1999.tb01372.x · Cited by 123 · see citing works
Leukocyte migration: Scent of the T zone
Cyster, J. G. (2000) · Current Biology · doi:10.1016/s0960-9822(99)00253-5 · Cited by 113 · see citing works
TREM-1: A new regulator of innate immunity in sepsis syndrome
Nathan, C., & Ding, A. H. (2001) · Nature Medicine · doi:10.1038/87846 · Cited by 100 · see citing works
Myeloma based expression system for production of large mammalian proteins
Traunecker, A. (1991) · Trends in biotechnology · doi:10.1016/0167-7799(91)90038-j · Cited by 95 · see citing works
Davis, W., Harrison, P. T., Hutchinson, M. J., & Allen, J. M. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07019.x · Cited by 95 · see citing works
T cell-dependent induction of NF-kappa B in B cells.
Lalmanach, A.-C., Chiles, T. C., Parker, D. C., & Rothstein, T. L. (1993) · The Journal of Experimental Medicine · doi:10.1084/jem.177.4.1215 · Cited by 88 · see citing works
CD40L: a multi-functional ligand
Armitage, R. J., Maliszewski, C. R., Alderson, M. R., et al. (1993) · Seminars in Immunology · doi:10.1006/smim.1993.1046 · Cited by 84 · see citing works
Petschner, F., Zimmermann, C., Strasser, A., Grillot, D., Núñez, G., & Pircher, H. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199802)28:02 · Cited by 77 · see citing works
syk protein tyrosine kinase regulates Fc receptor γ‐chain‐mediated transport to lysosomes
Bonnerot, C., Briken, V., Brachet, V., Lankar, D., Cassard, S., Jabrì, B., & Amigorena, S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.16.4606 · Cited by 77 · see citing works
Mason, L. H., Willette‐Brown, J., Mason, A. T., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.603 · Cited by 49 · see citing works
Hernández-Munaín, C., & Krangel, M. S. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.1.473-483.1994 · Cited by 49 · see citing works
Cloning and Characterization of a Novel Activating Ly49 Closely Related to Ly49A
Makrigiannis, A. P., Gosselin, P., Mason, L. H., Taylor, L. S., McVicar, D. W., Ortaldo, J. R., & Anderson, S. K. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.9.4931 · Cited by 40 · see citing works
Daws (2001) · doi:10.1002/1521-4141(200103)31:3
Flagged first, then by citations
Research works printed but not linked: 1
- Zlotnik A. Yoshie O. Chemokinesa new classification system and their role in immunity Immunity. 12 2000 121 127 10714678
Cited by
Sorted by citations
Variant of <i>TREM2</i> Associated with the Risk of Alzheimer's Disease
Jonsson, T., Stefansson, H., Steinberg, S., Jonsdottir, I., Jonsson, P. V., Snaedal, J., Bjornsson, S., Huttenlocher, J., Levey, A. I., Lah, J. J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211103 · Cited by 2,558 · see citing works
TREM2 Lipid Sensing Sustains the Microglial Response in an Alzheimer’s Disease Model
Wang, Y., Cella, M., Mallinson, K., Ulrich, J. D., Young, K. L., Robinette, M. L., Gilfillan, S., Krishnan, G. M., Sudhakar, S., Zinselmeyer, B. H., et al. (2015) · Cell · doi:10.1016/j.cell.2015.01.049 · Cited by 1,736 · see citing works
Self-citationInnate immune activation in neurodegenerative disease
Heneka, M. T., Kummer, M. P., & Latz, E. (2014) · Nature Reviews Immunology · doi:10.1038/nri3705 · Cited by 1,437 · see citing works
Takahashi, K., Rochford, C. D. P., & Neumann, H. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041611 · Cited by 1,124 · see citing works
Innate immunity in Alzheimer's disease
Heneka, M. T., Golenbock, D. T., & Latz, E. (2015) · Nature Immunology · doi:10.1038/ni.3102 · Cited by 902 · see citing works
Cutting Edge: TREM-2 Attenuates Macrophage Activation
Turnbull, I. R., Gilfillan, S., Cella, M., Aoshi, T., Miller, M., Piccio, L., Hernandez, M., & Colonna, M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.6.3520 · Cited by 688 · see citing works
Self-citationTREMs in the immune system and beyond
Colonna, M. (2003) · Nature Reviews Immunology · doi:10.1038/nri1106 · Cited by 701 · see citing works
Self-citationPaloneva, J., Manninen, T., Christman, G., Hovanes, K., Mandelin, J., Adolfsson, R., Bianchin, M., Bird, T., Miranda, R., Salmaggi, A., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/342259 · Cited by 683 · see citing works
TREM2 Modulation Remodels the Tumor Myeloid Landscape Enhancing Anti-PD-1 Immunotherapy
Molgora, M., Esaulova, E., Vermi, W., Hou, J., Chen, Y., Luo, J., Brioschi, S., Bugatti, M., Omodei, A. S., Ricci, B., et al. (2020) · Cell · doi:10.1016/j.cell.2020.07.013 · Cited by 656 · see citing works
“Therapeutic applications of macrophage colony-stimulating factor-1 (CSF-1) and antagonists of CSF-1 receptor (CSF-1R) signaling.”
InfluentialSelf-citationApolipoprotein E Is a Ligand for Triggering Receptor Expressed on Myeloid Cells 2 (TREM2)
Atagi, Y., Liu, C.-C., Painter, M. M., Chen, X.-F., Verbeeck, C., Zheng, H., Li, X., Rademakers, R., Kang, S. S., Xu, H., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.679043 · Cited by 587 · see citing works
Suárez‐Calvet, M., Kleinberger, G., Araque Caballero, M. Á., Brendel, M., Rominger, A., Alcolea, D., Fortea, J., Lleó, A., Blesa, R., Gispert, J. D., et al. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201506123 · Cited by 522 · see citing works
New insights into the role of TREM2 in Alzheimer’s disease
Gratuze, M., Leyns, C. E. G., & Holtzman, D. M. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0298-9 · Cited by 489 · see citing works
TREM2 sustains microglial expansion during aging and response to demyelination
Poliani, P. L., Wang, Y., Fontana, E., Robinette, M. L., Yamanishi, Y., Gilfillan, S., & Colonna, M. (2015) · Journal of Clinical Investigation · doi:10.1172/jci77983 · Cited by 525 · see citing works
Self-citationA role for TREM2 ligands in the phagocytosis of apoptotic neuronal cells by microglia
Hsieh, C. L., Koike, M., Spusta, S. C., Niemi, E. C., Yenari, M., Nakamura, M. C., & Seaman, W. E. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06042.x · Cited by 475 · see citing works
TREM2, microglia, and neurodegenerative diseases
Yeh, F. L., Hansen, D. V., & Sheng, M. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.03.008 · Cited by 440 · see citing works
Hamerman, J. A., Jarjoura, J. R., Humphrey, M. B., Nakamura, M. C., Seaman, W. E., & Lanier, L. L. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.4.2051 · Cited by 440 · see citing works
TREM2 variants: new keys to decipher Alzheimer disease pathogenesis
Colonna, M., & Wang, Y. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2016.7 · Cited by 418 · see citing works
Self-citationColonna, M. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-023-00837-1 · Cited by 394 · see citing works
Self-citationSchmid, C. D., Sautkulis, L. N., Danielson, P. E., Cooper, J., Hasel, K. W., Hilbush, B. S., Sutcliffe, J. G., & Carson, M. J. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01243.x · Cited by 351 · see citing works
Humanized TREM2 mice reveal microglia-intrinsic and -extrinsic effects of R47H polymorphism
Song, W. M., Joshita, S., Zhou, Y., Ulland, T. K., Gilfillan, S., & Colonna, M. (2018) · Journal of Experimental Medicine · doi:10.1084/jem.20171529 · Cited by 305 · see citing works
Self-citationCoding variants in TREM2 increase risk for Alzheimer's disease
Jin, S. C., Benitez, B. A., Karch, C. M., Cooper, B., Skorupa, T., Carrell, D., Norton, J. B., Hsu, S., Harari, O., Cai, Y., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu277 · Cited by 314 · see citing works
DAP12/TREM2 deficiency results in impaired osteoclast differentiation and osteoporotic features
Paloneva, J., Mandelin, J., Kiialainen, A., Böhling, T., Prudlo, J., Hakola, P., Haltia, M., Konttinen, Y. T., & Peltonen, L. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030027 · Cited by 318 · see citing works
Wunderlich, P., Glebov, K., Kemmerling, N., Tien, N. T., Neumann, H., & Walter, J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.517540 · Cited by 296 · see citing works
Altered microglial response to Aβ plaques in APPPS1-21 mice heterozygous for TREM2
Ulrich, J. D., Finn, M. B., Wang, Y., Shen, A., Mahan, T. E., Jiang, H., Stewart, F. R., Piccio, L., Colonna, M., & Holtzman, D. M. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-20 · Cited by 302 · see citing works
Self-citationPattern Recognition by TREM-2: Binding of Anionic Ligands
Daws, M. R., Sullam, P. M., Niemi, E. C., Chen, T. T., Tchao, N. K., & Seaman, W. E. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.2.594 · Cited by 291 · see citing works
Carson, M. J., Cameron Thrash, J., & Walter, B. (2006) · Clinical Neuroscience Research · doi:10.1016/j.cnr.2006.09.004 · Cited by 299 · see citing works
Song, W., Hooli, B., Mullin, K., Jin, S. C., Cella, M., Ulland, T. K., Wang, Y., Tanzi, R. E., & Colonna, M. (2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.07.004 · Cited by 297 · see citing works
Self-citationEmerging roles of innate and adaptive immunity in Alzheimer’s disease
Chen, X., & Holtzman, D. M. (2022) · Immunity · doi:10.1016/j.immuni.2022.10.016 · Cited by 297 · see citing works
Blockade of TREM‐2 exacerbates experimental autoimmune encephalomyelitis
Piccio, L., Buonsanti, C., Mariani, M., Cella, M., Gilfillan, S., Cross, A. H., Colonna, M., & Panina‐Bordignon, P. (2007) · European Journal of Immunology · doi:10.1002/eji.200636837 · Cited by 284 · see citing works
Self-citationTREM2-Ligand Interactions in Health and Disease
Kober, D. L., & Brett, T. J. (2017) · Journal of Molecular Biology · doi:10.1016/j.jmb.2017.04.004 · Cited by 284 · see citing works
“Soluble TREM2 also increased transcription of inflammatory cytokines in microglia through NF-κB activation [109], a pathway that was not previously reported to be activated by cellular TREM2 signaling [88].”
BackgroundZhao, J., Zhao, J., Legge, K., & Perlman, S. (2011) · Journal of Clinical Investigation · doi:10.1172/jci59777 · Cited by 265 · see citing works
Dendritic and Natural Killer Cells Cooperate in the Control/Switch of Innate Immunity
Zitvogel, L. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20012040 · Cited by 268 · see citing works
Impact of TREM2R47H variant on tau pathology–induced gliosis and neurodegeneration
Gratuze, M., Leyns, C. E. G., Sauerbeck, A. D., St-Pierre, M.-K., Xiong, M., Kim, N., Serrano, J. R., Tremblay, M.-È., Kummer, T. T., Colonna, M., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci138179 · Cited by 252 · see citing works
Self-citationNeumann, H., & Takahashi, K. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.11.032 · Cited by 249 · see citing works
Liu, W., Taso, O., Wang, R., Bayram, S., Graham, A. C., Garcia-Reitboeck, P., Mallach, A., Andrews, W. D., Piers, T. M., Botia, J. A., et al. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa209 · Cited by 214 · see citing works
“TREM2 expression was first observed in macrophages and dendritic cells, but not granulocytes or monocytes (Bouchon et al. 2000; Bouchon et al. 2001; Daws et al. 2001).”
BackgroundMeilandt, W. J., Ngu, H., Gogineni, A., Lalehzadeh, G., Lee, S.-H., Srinivasan, K., Imperio, J., Wu, T., Weber, M., Kruse, A. J., et al. (2020) · The Journal of Neuroscience · doi:10.1523/jneurosci.1871-19.2019 · Cited by 210 · see citing works
“…described roles for Trem2 in osteoclast function (Cella et al., 2003; Paloneva et al., 2003), AKT and mTOR signaling (Ulland et al., 2017), attenuation of proinflammatory macrophage activation (Turnbull et al., 2006), chemotaxis (Mazaheri et al., 2017), and DAP12 signaling (Bouchon et al., 2001).”
BackgroundTREM-2 promotes macrophage survival and lung disease after respiratory viral infection
Wu, K., Byers, D. E., Jin, X., Agapov, E., Alexander-Brett, J., Patel, A. C., Cella, M., Gilfilan, S., Colonna, M., Kober, D. L., et al. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20141732 · Cited by 207 · see citing works
Li, R.-Y., Qin, Q., Yang, H.-C., Wang, Y.-Y., Mi, Y.-X., Yin, Y.-S., Wang, M., Yu, C.-J., & Tang, Y. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00542-y · Cited by 204 · see citing works
TREM2 in CNS homeostasis and neurodegenerative disease
Painter, M. M., Atagi, Y., Liu, C.-C., Rademakers, R., Xu, H., Fryer, J. D., & Bu, G. (2015) · Molecular Neurodegeneration · doi:10.1186/s13024-015-0040-9 · Cited by 169 · see citing works
Xiang, X., Piers, T. M., Wefers, B., Zhu, K., Mallach, A., Brunner, B., Kleinberger, G., Song, W., Colonna, M., Herms, J., et al. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0280-6 · Cited by 170 · see citing works
Self-citationTREM2, a DAP12-associated receptor, regulates osteoclast differentiation and function
Humphrey, M. B., Daws, M. R., Spusta, S. C., Niemi, E. C., Torchia, J. A., Lanier, L. L., Seaman, W. E., & Nakamura, M. C. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.051016 · Cited by 162 · see citing works
Genetics ignite focus on microglial inflammation in Alzheimer’s disease
Malik, M., Parikh, I., Vasquez, J. B., Smith, C., Tai, L., Bu, G., LaDu, M. J., Fardo, D. W., Rebeck, G. W., & Estus, S. (2015) · Molecular Neurodegeneration · doi:10.1186/s13024-015-0048-1 · Cited by 161 · see citing works
Haure-Mirande, J.-V., Audrain, M., Ehrlich, M. E., & Gandy, S. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00552-w · Cited by 159 · see citing works
Lue, L., Schmitz, C. T., Serrano, G., Sue, L. I., Beach, T. G., & Walker, D. G. (2015) · Brain Pathology · doi:10.1111/bpa.12190 · Cited by 154 · see citing works
TREM2 is associated with increased risk for Alzheimer’s disease in African Americans
Jin, S. C., Carrasquillo, M. M., Benitez, B. A., Skorupa, T., Carrell, D., Patel, D., Lincoln, S., Krishnan, S., Kachadoorian, M., Reitz, C., et al. (2015) · Molecular Neurodegeneration · doi:10.1186/s13024-015-0016-9 · Cited by 153 · see citing works
Giraldo, M., Lopera, F., Siniard, A. L., Corneveaux, J. J., Schrauwen, I., Carvajal, J., Muñoz, C., Ramirez-Restrepo, M., Gaiteri, C., Myers, A. J., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.02.016 · Cited by 147 · see citing works
Distinct Signaling Pathways Regulate TREM2 Phagocytic and NFκB Antagonistic Activities
Yao, H., Coppola, K., Schweig, J. E., Crawford, F., Mullan, M., & Paris, D. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00457 · Cited by 110 · see citing works
The intracellular domain of CD44 promotes the fusion of macrophages
Cui, W. (2006) · Blood · doi:10.1182/blood-2005-05-1902 · Cited by 110 · see citing works
Structure, expression pattern and biological activity of molecular complex TREM-2/DAP12
Paradowska-Gorycka, A., & Jurkowska, M. (2013) · Human Immunology · doi:10.1016/j.humimm.2013.02.003 · Cited by 103 · see citing works
Shifting paradigms: The central role of microglia in Alzheimer’s disease
Schwabe, T., Srinivasan, K., & Rhinn, H. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104962 · Cited by 84 · see citing works
Immunopathogenic mechanisms and immunoregulatory therapies in MASLD
He, Y., Chen, Y., Qian, S., van Der Merwe, S., Dhar, D., Brenner, D. A., & Tacke, F. (2025) · Cellular & Molecular Immunology · doi:10.1038/s41423-025-01307-5 · Cited by 81 · see citing works
“TREM2 was fi rst cloned from human PBMCs in 2000 [32, 33].”
The innate immune system in Alzheimer's disease
Boutajangout, A., & Wisniewski, T. (2013) · International Journal of Cell Biology · doi:10.1155/2013/576383 · Cited by 69 · see citing works
Microglia, Trem2, and Neurodegeneration
Shi, Q., Gutierrez, R. A., & Bhat, M. A. (2025) · The Neuroscientist · doi:10.1177/10738584241254118 · Cited by 69 · see citing works
Lue, L.-F., Schmitz, C., & Walker, D. G. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2014.09.050 · Cited by 63 · see citing works
Behavioral and transcriptomic analysis of Trem2-null mice: not all knockout mice are created equal
Kang, S. S., Kurti, A., Baker, K. E., Liu, C.-C., Colonna, M., Ulrich, J. D., Holtzman, D. M., Bu, G., & Fryer, J. D. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddx366 · Cited by 62 · see citing works
Self-citationInnate Immune Response Gene Expression Profiles of N9 Microglia Are Pathogen-Type Specific
McKimmie, C. S., Roy, D., Forster, T., & Fazakerley, J. K. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.03.012 · Cited by 51 · see citing works
Regulation of microglial survival and proliferation in health and diseases
Ulland, T. K., Wang, Y., & Colonna, M. (2015) · Seminars in Immunology · doi:10.1016/j.smim.2016.03.011 · Cited by 43 · see citing works
Self-citationAlzheimer’s disease: rare variants with large effect sizes
Del-Aguila, J. L., Koboldt, D. C., Black, K., Chasse, R., Norton, J., Wilson, R. K., & Cruchaga, C. (2015) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2015.07.008 · Cited by 41 · see citing works
Obst, J., Hall-Roberts, H. L., Smith, T. B., Kreuzer, M., Magno, L., Di Daniel, E., Davis, J. B., & Mead, E. (2021) · Scientific Reports · doi:10.1038/s41598-021-96144-7 · Cited by 36 · see citing works
Etxeberria, A., Shen, Y.-A. A., Vito, S., Silverman, S. M., Imperio, J., Lalehzadeh, G., Soung, A. L., Du, C., Xie, L., Choy, M. K., et al. (2024) · The Journal of Neuroscience · doi:10.1523/jneurosci.2347-23.2024 · Cited by 34 · see citing works
Whittaker, G. C., Orr, S. J., Quigley, L., Hughes, L., Francischetti, I. M. B., Zhang, W., & McVicar, D. W. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.038398 · Cited by 33 · see citing works
TREM2: Keeping Pace With Immune Checkpoint Inhibitors in Cancer Immunotherapy
Qiu, H., Shao, Z., Wen, X., Jiang, J., Ma, Q., Wang, Y., Huang, L., Ding, X., & Zhang, L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.716710 · Cited by 32 · see citing works
Contributions of triggering-receptor-expressed-on-myeloid-cells-2 to neurological diseases
Han, J., Wang, M., Ren, M., & Lou, H. (2017) · International Journal of Neuroscience · doi:10.1080/00207454.2016.1264072 · Cited by 30 · see citing works
Vautheny, A., Duwat, C., Aurégan, G., Joséphine, C., Hérard, A.-S., Jan, C., Mitja, J., Gipchtein, P., Gaillard, M.-C., Buée, L., et al. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105398 · Cited by 28 · see citing works
Varnum, M. M., Clayton, K. A., Yoshii-Kitahara, A., Yonemoto, G., Koro, L., Ikezu, S., & Ikezu, T. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.759159 · Cited by 22 · see citing works
- Authors
- Bouchon, A., Hernández-Munain, C., Cella, M., & Colonna, M.
- Affiliations
- aBasel Institute for Immunology, CH-4005 Basel, Switzerland
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2001-10-15
- Volume
- 194
- Issue
- 8
- Pages
- 1111-1122
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2193511
- OpenAlex
- W2114829829
- Cited by
- 460
- References
- 92
- Citations by year
- 2026: 12 · 2025: 20 · 2024: 21 · 2023: 20 · 2022: 26 · 2021: 23 · 2020: 25 · 2019: 15 · 2018: 21 · 2017: 21 · 2016: 17 · 2015: 22 · 2014: 24 · 2013: 15 · 2012: 11
- FWCI
- 6.06
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › Inflammation biomarkers and pathways
- Keywords
- DAP12, TREM2, dendritic cell maturation, dendritic cell survival, monocyte-derived dendritic cells, tyrosine kinase signaling, ERK signaling, antigen presentation
- MeSH terms
- NF-KappaB Inhibitor alpha, Triggering Receptor Expressed on Myeloid Cells-1, Animals, Histocompatibility Antigens Class II, Cell Differentiation, Cell Line, Cell Survival, Dendritic Cells, DNA-Binding Proteins, Enzyme Activation, Hematopoietic Stem Cells, Humans, Membrane Glycoproteins, Membrane Proteins, Mice, Inbred BALB C, Monocytes, Protein-Tyrosine Kinases, Receptors, Immunologic, Signal Transduction, Antigens, CD, Up-Regulation, NF-kappa B, CD40 Antigens, Receptors, Chemokine, Mitogen-Activated Protein Kinase 1, I-kappa B Proteins, Mitogen-Activated Protein Kinases, p38 Mitogen-Activated Protein Kinases, Mitogen-Activated Protein Kinase 3, Adaptor Proteins, Signal Transducing, Mice, B7-2 Antigen, Receptors, CCR7
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review